Unity Biotechnology, Inc.UBXNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank25
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P25
Within normal range
vs 5Y Ago
-1.8x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | -37.47% |
| 2023 | -43.57% |
| 2022 | -4.00% |
| 2021 | -42.96% |
| 2020 | -5.14% |
| 2019 | 20.46% |
| 2018 | 57.62% |
| 2017 | 172.66% |
| 2016 | 0.00% |